PHM:BME
Pharma Mar SA
ā§Ŧā§Ŧ.ā§Žā§ĻâŦ
arrow_downward
-ā§Ļ.ā§Ļā§%(-ā§Ļ.ā§Ļā§Ģā§Ļ) ā§§ āĻĻāĻŋ
ā§Ģ āύāĻā§, ⧍:⧍ā§Ē:ā§Šā§Ģ PM GMT +ā§§ · EUR
search
āϏāĻŦ āϏāĻŋāĻŽā§āĻŦāϞ
| āϏāĻŋāĻŽā§āĻŦāϞ | āĻĻāĻžāĻŽ | āĻĒāϰāĻŋāĻŦāϰā§āϤāύ āĻāϰā§āύ | % āĻĒāϰāĻŋāĻŦāϰā§āϤāύ |
|---|
insights_autoPHM-āĻāϰ āĻāύā§āϝ āϏā§āϰāĻž āĻāύāϏāĻžāĻāĻ āĻā§āύāĻžāϰā§āĻ āĻāϰāĻž āĻšāĻā§āĻā§...
āĻā§āϞā§āύ
ā§Ŧā§.ā§Ŧā§ĻâŦ
āϏāϰā§āĻŦāĻžāϧāĻŋāĻ
ā§Ŧā§.ā§Žā§ĻâŦ
āϏāϰā§āĻŦāύāĻŋāĻŽā§āύ
ā§Ŧā§Ŧ.ā§Ļā§ĻâŦ
āĻŽāĻžāϰā§āĻā§āĻ āĻā§āϝāĻžāĻĒ
⧧⧍ā§Ļ.⧍ā§Ē āĻā§
āĻ
ā§āϝāĻžāĻāĻžāϰā§āĻ āĻāϞāĻŋāĻāĻŽ
ā§Šā§Š.ā§Ŧā§ŽÂ āĻšāĻž
āĻāϞāĻŋāĻāĻŽ
⧍ā§Ē.ā§Ļā§Ē āĻšāĻž
āĻĄāĻŋāĻāĻŋāĻĄā§āύā§āĻĄ
ā§§.ā§Ģā§Ļ%
āĻā§ā§āĻžāϰā§āĻāĻžāϰāϞāĻŋ āĻĄāĻŋāĻāĻŋāĻĄā§āύā§āĻĄ
ā§Ļ.⧍ā§ĢâŦ
āĻāĻā§āϏ-āĻĄāĻŋāĻāĻŋāĻĄā§āύā§āĻĄā§āϰ āϤāĻžāϰāĻŋāĻ
ā§ āĻā§āύ, ⧍ā§Ļā§¨ā§Š
P/E āϰā§āĻļāĻŋāĻ
ā§§ā§Ŧ.ā§ā§Ģ
ā§Ģ⧍ āϏāĻĒā§āϤāĻžāĻšā§āϰ āϏāϰā§āĻŦā§āĻā§āĻ āĻĻāĻžāĻŽ
ā§§ā§Ļā§Ģ.⧍ā§ĻâŦ
ā§Ģ⧍ āϏāĻĒā§āϤāĻžāĻšā§āϰ āϏāϰā§āĻŦāύāĻŋāĻŽā§āύ āĻĻāĻžāĻŽ
ā§Ŧ⧍.ā§Ļā§ĻâŦ
EPS
ā§Š.⧝⧝âŦ
āĻāĻāĻāϏā§āĻā§āϝāĻžāύā§āĻĄāĻŋāĻ āĻļā§ā§āĻžāϰ
ā§§.ā§Žā§Ļ āĻā§
āĻāϰā§āĻŽā§āϏāĻāĻā§āϝāĻž
ā§Ģā§Ļā§Ģ
āĻā§āϞā§āύ
ā§Ŧā§.ā§Ŧā§ĻâŦ
āϏāϰā§āĻŦāĻžāϧāĻŋāĻ
ā§Ŧā§.ā§Žā§ĻâŦ
āϏāϰā§āĻŦāύāĻŋāĻŽā§āύ
ā§Ŧā§Ŧ.ā§Ļā§ĻâŦ
āĻŽāĻžāϰā§āĻā§āĻ āĻā§āϝāĻžāĻĒ
⧧⧍ā§Ļ.⧍ā§Ē āĻā§
āĻ
ā§āϝāĻžāĻāĻžāϰā§āĻ āĻāϞāĻŋāĻāĻŽ
ā§Šā§Š.ā§Ŧā§ŽÂ āĻšāĻž
āĻāϞāĻŋāĻāĻŽ
⧍ā§Ē.ā§Ļā§Ē āĻšāĻž
āĻĄāĻŋāĻāĻŋāĻĄā§āύā§āĻĄ
ā§§.ā§Ģā§Ļ%
āĻā§ā§āĻžāϰā§āĻāĻžāϰāϞāĻŋ āĻĄāĻŋāĻāĻŋāĻĄā§āύā§āĻĄ
ā§Ļ.⧍ā§ĢâŦ
āĻāĻā§āϏ-āĻĄāĻŋāĻāĻŋāĻĄā§āύā§āĻĄā§āϰ āϤāĻžāϰāĻŋāĻ
ā§ āĻā§āύ, ⧍ā§Ļā§¨ā§Š
P/E āϰā§āĻļāĻŋāĻ
ā§§ā§Ŧ.ā§ā§Ģ
ā§Ģ⧍ āϏāĻĒā§āϤāĻžāĻšā§āϰ āϏāϰā§āĻŦā§āĻā§āĻ āĻĻāĻžāĻŽ
ā§§ā§Ļā§Ģ.⧍ā§ĻâŦ
ā§Ģ⧍ āϏāĻĒā§āϤāĻžāĻšā§āϰ āϏāϰā§āĻŦāύāĻŋāĻŽā§āύ āĻĻāĻžāĻŽ
ā§Ŧ⧍.ā§Ļā§ĻâŦ
EPS
ā§Š.⧝⧝âŦ
āĻāĻāĻāϏā§āĻā§āϝāĻžāύā§āĻĄāĻŋāĻ āĻļā§ā§āĻžāϰ
ā§§.ā§Žā§Ļ āĻā§
āĻāϰā§āĻŽā§āϏāĻāĻā§āϝāĻž
ā§Ģā§Ļā§Ģ
āĻāĻŦāϰā§āϰ āϏā§āĻā§āϰāĻŋ
āĻā§ā§āĻŦ āϏā§āϰā§āϏ āĻ āĻāĻŦāϰā§āϰ āĻĒāĻžāϰā§āĻāύāĻžāϰāĻĻā§āϰ āĻĨā§āĻā§
Yahoo Finance
·
ā§Šā§Ļ āĻŽāĻŋāύāĻŋāĻ āĻāĻā§
Famed XRP Analyst Eyes $10 as New York Stock Exchange Deal Fuels Adoption Claims
Tech Funding News
·
ā§ āĻŽāĻŋāύāĻŋāĻ āĻāĻā§
Dronamics is targeting a Nasdaq listing at a $400m valuation. Can it still fund its defence expansion with a smaller SPAC trust?
FinancialContent
·
ā§§ āĻāĻŖā§āĻāĻž āĻāĻā§
LSIâs (NASDAQ:LYTS) Q3 CY2026 earnings results: revenue in line with expectations
The Motley Fool
·
ā§§ āĻāĻŖā§āĻāĻž āĻāĻā§
3 Stocks Yielding Triple the S&P 500 to Buy in November
Pharma Mar SA āϏāĻŽā§āĻĒāϰā§āĻā§
āϏāĻŋāĻāĻ-
āĻāϰā§āĻŽā§ā§Ģā§Ļā§Ģ
āĻĒā§āϰāϤāĻŋāώā§āĻ āĻžāϰ āϤāĻžāϰāĻŋāĻā§§ā§¯ā§Žā§Ŧ
āĻšā§āĻĄāĻā§ā§āĻžāϰā§āĻāĻžāϰ-
āϏā§āĻā§āĻāϰ-
Industry-
āĻā§ā§āĻŦāϏāĻžāĻāĻpharmamar.com